TREATMENT OF ESSENTIAL THROMBOCYTHEMIA IN PATIENTS AT LOW AND HIGH-RISK OF THROMBOSIS - A PROSPECTIVE-STUDY

被引：0
|
作者：
FINAZZI, G
CORTELAZZO, S
RUGGERI, M
VESTRI, O
GALLI, M
RODEGHIERO, F
BARBUI, T
机构：
[1] OSPED RIUNITI BERGAMO,DIV HEMATOL,I-24100 BERGAMO,ITALY
[2] OSPED CIVILE,DIV HEMATOL,VICENZA,ITALY
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：956 / 956
页数：1
相关论文
共 50 条
  • [1] HYDROXYUREA FOR THE TREATMENT OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND HIGH-RISK OF THROMBOSIS - A PROSPECTIVE, RANDOMIZED TRIAL
    CORTELAZZO, S
    FINAZZI, G
    RUGGERI, M
    VESTRI, O
    GALLI, M
    RODEGHIERO, F
    BARBUI, T
    [J]. BLOOD, 1994, 84 (10) : A517 - A517
  • [2] HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS
    CORTELAZZO, S
    FINAZZI, G
    RUGGERI, M
    VESTRI, O
    GALLI, M
    RODEGHIERO, F
    BARBUI, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17): : 1132 - 1136
  • [3] Treatment of Essential Thrombocythemia in Europe: An Observational Study of 3649 High-Risk Patients in Exels
    Birgegard, Gunnar
    Besses, Carlos
    Griesshammer, Martin
    Gugliotta, Luigi
    Harrison, Claire N.
    Hamdani, Mohamed
    Achenbach, Heinrich
    Kiladjian, Jean-Jacques
    [J]. BLOOD, 2014, 124 (21)
  • [4] A PROSPECTIVE-STUDY OF HISTOCOMPATABILITY TESTING FOR KERATOPLASTY IN HIGH-RISK PATIENTS
    OZDEMIR, O
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1986, 70 (03) : 183 - 186
  • [5] Prognostic risk model for patients with high-risk polycythemia vera and essential thrombocythemia
    Mangaonkar, Abhishek A.
    Hoversten, Katherine P.
    Gangat, Naseema
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (03) : 247 - 252
  • [6] The evaluation of patients with essential thrombocythemia in terms of risk of thrombosis
    Sunu, Cenk
    Gunes, Ahmet Kursad
    Akat, Gulten Korkmaz
    Kalpakci, Yasin
    Ceran, Funda
    Dagdas, Simten
    Ozet, Gulsum
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (03): : 385 - 389
  • [7] NEONATAL RESUSCITATION IN HIGH-RISK DELIVERIES - A PROSPECTIVE-STUDY
    HALL, RT
    BROWN, MJ
    [J]. MISSOURI MEDICINE, 1983, 80 (05) : 249 - 252
  • [8] Treatment with pegylated interferon α (PegIntron) for high-risk Essential Thrombocythemia:: Results of a phase II study
    Langer, C
    Lengfelder, E
    Thiele, J
    Kvasnika, HM
    Pahl, H
    Matzdorff, A
    Stade, B
    Schauer, S
    Gisslinger, H
    Dohner, H
    Griesshammer, M
    [J]. BLOOD, 2004, 104 (11) : 426A - 426A
  • [9] HIGH-RISK FOR VASCULAR EVENTS IN PATIENTS WITH PROTRUDING AORTIC ATHEROMAS - A PROSPECTIVE-STUDY
    TUNICK, PA
    KATZ, E
    FREEDBERG, R
    ROSENZWEIG, BP
    PEREZ, J
    KRONZON, I
    [J]. CIRCULATION, 1993, 88 (04) : 314 - 314
  • [10] HIGH-RISK FOR VASCULAR EVENTS IN PATIENTS WITH PROTRUDING AORTIC ATHEROMAS - A PROSPECTIVE-STUDY
    TUNICK, PA
    ROSENZWEIG, BP
    KATZ, ES
    FREEDBERG, RS
    PEREZ, JL
    KRONZON, I
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) : 1085 - 1090
12345